Reimbursement Issues with Hormonal Therapies for Prostate Cancer

Reviews in Urology

M. Ray Painter¹ 

[1] Physician Reimbursement Systems, Inc., Denver, CO

关键词: LHRH agonists;    Average sale price;    Average wholesale price;    Modifier −25;   

DOI  :  

学科分类：基础医学

来源: MedReviews, LLC

【 摘 要 】

Reimbursement issues surrounding the treatment of prostate cancer with hormonal therapies have changed dramatically in the past 2 years. The ultimate goal for urologists when making treatment decisions regarding LHRH agonist use is to continue to provide hassle-free, complete care for patients, including whatever medications they need. This is still fully possible under the new rules without sacrificing the opportunity to profit from office-based administration of injectable medications.

【 授权许可】

Unknown